Drugs / personalized DC vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03671720 | Sep 2018 → Dec 2021 | metastatic malignant neoplasm | Capital Medical University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | personalized DC vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03671720 ↗ |
| Modality | Vaccine | “The study is to investigate the safety and efficacy of dendritic cells vaccines pulsed with autologous whole tumor cell lysate” NCT03671720 ↗ |
| Route | Other | “administered intranodally” NCT03671720 ↗ |